APA (7th ed.) Citation
(2026). RETRACTION: PLK2 Phosphorylates and Inhibits Enriched TAp73 in Human Osteosarcoma Cells. Cancer Medicine.
Chicago Style (17th ed.) Citation
"RETRACTION: PLK2 Phosphorylates and Inhibits Enriched TAp73 in Human Osteosarcoma Cells." Cancer Medicine 2026.
MLA (9th ed.) Citation
"RETRACTION: PLK2 Phosphorylates and Inhibits Enriched TAp73 in Human Osteosarcoma Cells." Cancer Medicine, 2026.
Warning: These citations may not always be 100% accurate.